All news

Cardinal Health reaffirms fiscal 2027 guidance, extends CVS deal

Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash

Cardinal Health shares reached EUR 208.55, up 0.58%, as the company highlighted real-time visibility and data-driven intervention through its OptiFreight Logistics business. Cardinal Health reaffirmed fiscal 2027 non-GAAP earnings per share guidance of USD 12.40-12.60 and extended its pharmaceutical distribution agreements with CVS Health through June 30, 2032. Analysts carry a consensus target of $270.33 versus a $232.16 price, implying 16.4% upside, with 14 Buy, 3 Hold and no Sell ratings.

Read original source

CAH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.